In unfavorable neuroblastomas CaSR is silenced by epigenetic and genetic mechanisms (Casala et al., 2013), while in parathyroid tumors CaSR loss is independent of DNA methylation (Varshney et al., 2013). This evidence concerns the gene CASR and tumor of parathyroid gland.